Star Cap is a project aimed at developing a mini/microfluidic platform for the determination and management of individual oncogenetic risk associated with the interplay between gut microbiome and nutrition. The above platform, by recapitulating in vitro the complex interaction between diet and intestinal microbiome, not only quantifies the individual risk of possessing an oncogenic microbiome but serves as a support for two specific personalized medicine services.

Specifically, the operation of the platform is based on a series of proprietary selective growth media that allow the fecal microbiome to "magnify" the production of onco-methanolites.

Platform also integrates a cellular system capable of deciding and quantifying the genotoxic effect of the aforementioned metabolites.